Contract Research Organizations: Difference between revisions
(Create page; add Eurofins Panlabs) |
(Add PDSP) |
||
Line 1: | Line 1: | ||
Contract research organizations are companies that will perform specific in vitro and in vivo assays to testing the activity of compounds or therapies. Listed here are companies that the Shoichet lab has either worked with or considered working with in the past. | Contract research organizations are companies that will perform specific in vitro and in vivo assays to testing the activity of compounds or therapies. Listed here are companies that the Shoichet lab has either worked with or considered working with in the past. | ||
==[http://pdsp.med.unc.edu PDSP]== | |||
The NIMH Psychoactive Drug Screening Program run by the Roth lab at UNC Chapel Hill, has been a close collaborator in performing in vitro binding and functional assays for almost all GPCR targets and and several transporters. If the PDSP has the assay, they are typically our first choice. | |||
==[https://www.eurofinspanlabs.com/Panlabs Eurofins Panlabs]== | ==[https://www.eurofinspanlabs.com/Panlabs Eurofins Panlabs]== |
Revision as of 14:22, 17 June 2014
Contract research organizations are companies that will perform specific in vitro and in vivo assays to testing the activity of compounds or therapies. Listed here are companies that the Shoichet lab has either worked with or considered working with in the past.
PDSP
The NIMH Psychoactive Drug Screening Program run by the Roth lab at UNC Chapel Hill, has been a close collaborator in performing in vitro binding and functional assays for almost all GPCR targets and and several transporters. If the PDSP has the assay, they are typically our first choice.
Eurofins Panlabs
Located in Taiwan, they have 1,350 assays covering the following target classes
- Cytokine/Chemokine (41)
- GPCR (270)
- Ion Channel (41)
- Kinase (154)
- Nuclear Receptor (16)
- Other (15)
- Phosphatase (31)
- Phosphodiesterase (19)
- Protease (51)
- Transporter (19)
They were used by both Henry Lin and Matthew O'Meara (2013-2014) and they gave reasonable results at reasonable prices.